Yiqiang Da - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Yiqiang Da

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Frontiers in Oncology|September 8, 2025

A high stroma-tumor ratio is associated with an immunosuppressive tumor microenvironment and a poor prognosis in bladder cancerYiqiang Da, Zirong Lu, Zijian Zhu, et al.

Journal of Visualized Experiments : Jove|December 22, 2025

Analysis Based on TCGA Data and Single-cell Data, taking TRPM4 as an ExampleYiqiang Da, Xuerui Chen, Lanxin Yu, et al.

Discover Oncology|November 20, 2025

Transient Receptor Potential Melastatin 4 (TRPM4) is associated with an immuno-stimulatory TME and better prognosis in BLCAYiqiang Da, Xuerui Chen, Lanxin Yu, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Frontiers in Oncology|September 8, 2025

A high stroma-tumor ratio is associated with an immunosuppressive tumor microenvironment and a poor prognosis in bladder cancerYiqiang Da, Zirong Lu, Zijian Zhu, et al.

Journal of Visualized Experiments : Jove|December 22, 2025

Analysis Based on TCGA Data and Single-cell Data, taking TRPM4 as an ExampleYiqiang Da, Xuerui Chen, Lanxin Yu, et al.

Discover Oncology|November 20, 2025

Transient Receptor Potential Melastatin 4 (TRPM4) is associated with an immuno-stimulatory TME and better prognosis in BLCAYiqiang Da, Xuerui Chen, Lanxin Yu, et al.

Pageof 1